ZDS-16042-43886 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-01
Registered in v-safe
2021-01-01
Dose 1 — Pfizer-BioNTech
2021-01-01
Health check-in — day 0, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Redness · Fatigue or tiredness

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-10
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-22
Dose 2 — Pfizer-BioNTech
2021-01-22
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-07
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-07
Survey response — day 42, dose 2
MedDRA: Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activities

Free text: Mild sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-23
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-22
Survey response — 12 months, dose 2
MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID-19, pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-25
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-01	Pfizer-BioNTech
2	2021-01-22	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-22	Unsuccessful

Free text

Release 5 — day 42, dose 2

2021-03-07

Symptoms: Mild sore throat

Release 11 — 12 months, dose 2

2022-01-22

Symptoms: COVID-19, pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release